Cripto-1 Antikörper (Internal Region)

Produktnummer ABIN2465558

Produktdetails anti-Cripto-1 Antikörper

Target: Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))

Bindungsspezifität: Internal Region

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Cripto-1 Antikörper ist unkonjugiert

Applikation: ELISA

Aufreinigung: Cripto-1 antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: Cripto-1 antibody was raised against a 16 amino acid synthetic peptide near the internal region of Cripto-1.

Anwendungsinformationen

Applikationshinweise: ELISA: Antibody detection limit dilution 1:32,000. Western Blot: Approximately 55 kDa band in human breast, placenta and testis lysates after 0.1 μg/mL antibody staining.6 kDa according to NP_115934.1. The 55 kDa band was successfully blocked by incubation with the immunizing peptide.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 500 μg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20 °C.

Details zu Cripto-1

Target: Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))

Andere Bezeichnung: Cripto-1 (TDGF1.3 Produkte)

Gen-ID: 55997

NCBI Accession: NP_115934

UniProt: P0CG37